Tag: OOS decision tree

Case Study: OOS Investigation Breakdown and Regulatory Resolution

Out-of-Specification (OOS) results can trigger major compliance concerns in pharmaceutical manufacturing — especially when they occur during long-term stability studies. This case-based article walks through a real-world OOS incident, its detailed investigation process, root cause determination, and regulatory resolution steps. It offers a practical learning opportunity for QA professionals, analysts, and regulatory affairs teams. 🔍…

Out-of-Specification (OOS) Stability Studies, Regulatory Guidelines

Designing a Decision Tree for OOS Evaluation in Stability Testing

Out-of-Specification (OOS) results in stability testing can pose major regulatory and operational hurdles. A well-designed decision tree helps pharma professionals evaluate OOS outcomes systematically, ensuring compliance with USFDA, EMA, and other regulatory expectations. By clearly defining the path from initial detection to final disposition, organizations can streamline root cause analysis, reduce subjective judgments, and minimize…

Out-of-Specification (OOS) Stability Studies, Regulatory Guidelines